A new report from Reuters 1 details how the residents of Kalundborg, Denmark, are reacting to the news of the looming layoffs ...

Wegovy maker Novo Nordisk has cut a U.S. sales team focused on obesity and diabetes education for healthcare providers, ...

In today’s Pharmaceutical Executive Daily, we cover the impact of Novo Nordisk layoffs on its hometown in Denmark, GSK’s ...

Because of its size, the drugmaker has an outsize effect on the country. Now, as it sheds jobs, forecasts for Denmark’s ...

Novo Nordisk and Bristol Myers Squibb plan nearly 550 New Jersey job cuts as part of global restructuring and cost-saving ...

This year, Novo Nordisk and Merck announced significant layoffs, with Novo planning to axe about 9,000 employees and Merck ...

The four-star fund is in the top 22% of its peers on a one-year basis, up 19%, versus 16.2% for the category and 19% for the ...

Ozempic and Wegovy maker Novo Nordisk says it will layoff about 9,000 employees of its global workforce as it restructures in ...

Novo Nordisk inflicted much pain—and much-needed pain—when president and CEO Maziar (Mike) Doustdar announced the company’s plans to lay off about 9,000 of its 78,400 employees, a spot check of ...

Both BMS and Novo Nordisk have, in recent months, announced steep layoffs as they strive to cut back on costs.

The pharmaceutical giant is slashing 11% of its workforce as it continues to lose market share. Novo Nordisk, the Danish pharmaceutical giant behind the popular weight-loss drugs Ozempic and Wegovy, ...